Collawound Art
Dressing, Wound, Drug. 510(k) K093351, from Collamatrix, Inc. (Taipei, TW). Product code FRO, class U.
As of Nov 19, 2026, K093351 is an FDA 510(k) held by Collamatrix, Inc., substantially equivalent on Jun 16, 2010 after 232 days, with no recalls tied to it in FDA's recall database.
- Review time: 232 days
- Recalls: 0
CollaWound ART is a wound dressing intended for use as a barrier to resist microbial colonization within the dressing and reduce microbial penetration through the dressing. CollaWound ART is intended for the management of wounds including: • partial and full thickness wounds • pressure ulcers • venous ulcers • diabetic ulcers • chronic vascular ulcers - tunneled/undermined wounds - surgical…
- Fortaderm Antimicrobial Wound DressingK051647 · Organogenesis, Inc. · Nov 8, 2005
- Xylos Xcell Antimicrobial DressingK024054 · Xylos Corporation · Mar 7, 2003
- Triad Hydrophilic Wound Dresssing (1964, 2.5 oz); Triad Hydrophilic Wound Dressing (1967, 6 oz)K260285 · Coloplast Corp. · Oct 26, 2026
- Actolind® (06.3637. Actolind® Gel Plus)K254168 · ACTO GmbH · Sep 22, 2026
- SkinSmart Antimicrobial HydroGelK254041 · Magic Science Supply, LLC · Sep 11, 2026
- Redermax® Antibacterial Wound MatrixK261646 · Beijing Kreate Medical Co., Ltd. · Aug 14, 2026
- Vashe Plus Antimicrobial SolutionK253665 · Urgo Medical North America, LLC · Aug 11, 2026
- SilverCeuticals® Antimicrobial Wound GelK251929 · Silverceuticals, Inc. · Jun 24, 2026
- Microdacyn Wound Irrigation SolutionK261023 · Sonoma Pharmaceuticals, Inc. · Jun 24, 2026
- Bonvadis®K261638 · Oneness Biotech Co., Ltd. · Jun 17, 2026
- Document
- 510(k) summary (PDF) ↗
- Type
- Abbreviated
- Received
- Oct 27, 2009
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files